Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review

被引：42
|
作者：
Uppendahl, Locke D. [1 ]
Dahl, Carly M. [2 ]
Miller, Jeffrey S. [3 ]
Felices, Martin [3 ]
Geller, Melissa A. [1 ]
机构：
[1] Univ Minnesota, Sch Med, Div Gynecol Oncol, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
来源：
FRONTIERS IN IMMUNOLOGY | 2018年 / 8卷
关键词：
natural killer cells; immunotherapy; gynecologic malignancy; ovarian cancer; cervical cancer; TUMOR-INFILTRATING LYMPHOCYTES; APOPTOSIS-INDUCING LIGAND; OVARIAN-CANCER PATIENTS; CLASS-I MOLECULES; ANTI-CD20; MONOCLONAL-ANTIBODY; PERIPHERAL-BLOOD LYMPHOCYTES; IFN-GAMMA PRODUCTION; UTERINE NK CELLS; ACTIVATING RECEPTOR; ADOPTIVE TRANSFER;
D O I：
10.3389/fimmu.2017.01825
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Harnessing the immune system has proven an effective therapy in treating malignancies. Since the discovery of natural killer (NK) cells, strategies aimed to manipulate and augment their effector function against cancer have been the subject of intense research. Recent progress in the immunobiology of NK cells has led to the development of promising therapeutic approaches. In this review, we will focus on the recent advances in NK cell immunobiology and the clinical application of NK cell immunotherapy in ovarian, cervical, and uterine cancer.
引用
收藏
页数：15
相关论文
共 50 条
  • [31] Current and Future States of Natural Killer Cell-Based Immunotherapy in Hepatocellular Carcinoma
    Nguyen, Tu
    Chen, Po -Chun
    Pham, Janet
    Kaur, Kawaljit
    Raman, Steven S.
    Jewett, Anahid
    Chiang, Jason
    CRITICAL REVIEWS IN IMMUNOLOGY, 2024, 44 (05)
  • [32] Natural killer cell-based immunotherapy in cancer: current insights and future prospects
    Sutlu, T.
    Alici, E.
    JOURNAL OF INTERNAL MEDICINE, 2009, 266 (02) : 154 - 181
  • [33] A critical role for natural killer cells in dendritic cell-based anticancer immunotherapy
    McLellan, Alexander D.
    ONCOIMMUNOLOGY, 2014, 3 (04):
  • [34] Natural killer cell-based cancer immunotherapy: from basics to clinical trials
    Shi, Yinghong
    Hao, Donglin
    Qian, Hui
    Tao, Zhimin
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [35] Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy
    Gaggero, Silvia
    Witt, Kristina
    Carlsten, Mattias
    Mitra, Suman
    FRONTIERS IN IMMUNOLOGY, 2021, 11
  • [36] Combination of natural killer cell-based immunotherapy and irreversible electroporation for the treatment of hepatocellular carcinoma
    Eresen, Aydin
    Yang, Jia
    Scotti, Alessandro
    Cai, Kejia
    Yaghmai, Vahid
    Zhang, Zhuoli
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (13)
  • [37] Natural Killer Cells in Liver Disease and Hepatocellular Carcinoma and the NK Cell-Based Immunotherapy
    Liu, Pingyi
    Chen, Lingling
    Zhang, Haiyan
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [38] Natural killer cell-based immunotherapeutic strategies
    Klingemann, HG
    CYTOTHERAPY, 2005, 7 (01) : 16 - 22
  • [39] Natural killer cell-based therapies in neuroblastoma
    Ghasempour, Abtin
    Mohseni, Rashin
    Sharif, Pouya Mahdavi
    Hamidieh, Amir Ali
    CELLULAR IMMUNOLOGY, 2025, 407
  • [40] A Transformable Supramolecular Bispecific Cell Engager for Augmenting Natural Killer and T Cell-Based Cancer Immunotherapy
    Chen, Yumiao
    Li, Wei
    Wang, Zhongqiu
    Yu, Yingying
    Li, Jie
    Ding, Yinghao
    Hu, Zhiwen
    Liu, Qian
    Yang, Zhimou
    Gao, Jie
    ADVANCED MATERIALS, 2024, 36 (03)
12345